疏血通联合依达拉奉治疗老年脑梗死的临床效果观察

目的：分析疏血通联合依达拉奉治疗老年脑梗死的临床效果。方法选取89例老年脑梗死患者，将其根据用药方法不同划分为两组。两组均给予常规治疗，参照组49例患者加用依达拉奉治疗，静脉滴注30 mg，2次/d，研究组40例患者在参照组基础上加用疏血通治疗，6 ml/次，1次/d。两组均10 d为1个疗程，比较两组的治疗效果及不良反应情况。结果研究组治疗4、14 d后的ESS积分明显高于参照组（P〈0.05）；研究组的有效率为92.5%，明显高于参照组的81.6%（P〈0.05）；两组的不良反应发生率比较，差异无统计学意义（P〉0.05），两组用药后有轻微不良反应，不需特殊处理，可自行消失。结论疏血通联合依达拉奉治疗老年脑梗死的效果显著，安全可靠，值得临床推广应用。

Clinical effect observation of Shuxuetong combined with edaravone in the treatment of cerebral infarction in elderly patients

Objective To analyze clinical effect of shuxuetong combined with edaravone in the treatment of cerebral in-farction in elderly patients. Methods 89 elderly patients with cerebral infarction were selected and they were divided into the two groups based on different medication regimes.The routine treatment was given to the two groups,and 49 pa-tients in the reference group was intravenously given 30 mg of edaravone on the basis of the routine treatment,twice a day.40 patients in the research group was given 6 ml of Shuxuetong based on the treatment in the reference group,once a day.Patients of the two groups were continuously given the medication for 10 days as a treatment period,and the treat-ment effect and adverse reaction in the two groups were compared. Results ESS score after 4,14 days treatment in the research group were significantly higher than those in the control group （P〈0.05）;the effective rate in the research group （92.5%） was obviously higher than that in the reference group （81.6%） （P〈0.05）;there was no statistical difference of the incidence rate of adverse reaction in the two groups （P〉0.05）,minor adverse effects were detected in the two groups af-ter the medication, but they could disappear without special handling. Conclusion Shuxuetong combined with edar-avone in the treatment of cerebral infarction in elderly patients has a significant curative effect and is safe and reliable, which is worthy of clinical promotion and application.